Physician profile
Gary F Earle
NPI 1316908452
$5,663.92
in general payments reported to CMS, 2019-2025
24 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $1,291 · 2021: $438 · 2022: $287 · 2023: $1,118 · 2024: $1,138 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,485.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,485.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,928.52 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, C3 Delivery System, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Atricure, INC. | $1,865.41 | 2020-2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $719.58 | 2019-2025 | Sapien 3 Ultra Resilia, Konect Resilia, Mitris Resilia Mitral Valve |
| Abbott Laboratories | $200.53 | 2019-2023 | Epic |
| Baxter Healthcare | $192.58 | 2024 | Preveleak |
| Medtronic, INC. | $132.29 | 2023-2025 | Corevalve Evolut R, Penditure, Endurant Iis |
| Olympus America INC. | $81.05 | 2020-2023 | Evis Exera II Ultrasonic Bronchofibervideoscope, Evis Exera III Bronchovideoscope, 4k Cable 8.5m |
| Angiodynamics, INC. | $75.15 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $72.09 | 2024 | Keytruda |
| Galvanize Therapeutics, INC | $48.89 | 2024 | Aliya System |
| Lsi Solutions INC | $43.57 | 2019-2023 | Cor Knot |
| Innovation Technologies INC | $35.97 | 2024 | Irrisept |
| Veran Medical Technologies, INC. | $28.46 | 2021 | |
| Getinge USA Sales, LLC | $28.20 | 2021 | |
| Corcym INC | $26.38 | 2023 | Perceval |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $25.97 | 2023 | |
| Shionogi INC | $24.90 | 2023 | Fetroja |
| Silk Road Medical, INC. | $23.25 | 2022 | |
| Cook Medical LLC | $22.10 | 2021 | |
| Boston Scientific Corporation | $21.94 | 2023 | |
| Chiesi USA, INC. | $19.94 | 2023 | Cleviprex |
| Ethicon US, LLC | $19.28 | 2019 | |
| Cardiovascular Systems INC. | $14.94 | 2023 | Diamondback Peripheral |
| Shockwave Medical, INC | $12.93 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Earle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.